Brotizolam (marketed under brand name Lendormin) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
| File:Brotizolam.png | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Elimination half-life | ? |
| Excretion | Renal |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.055.404 |
| Chemical and physical data | |
| Formula | C15H10BrClN4S |
| Molar mass | 393.7 |
Brotizolam is not approved for sale in the United States or Canada.
External links
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |